Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 112, Issue 3, Pages 502-508Publisher
WILEY
DOI: 10.1002/ijc.20435
Keywords
arginine deiminase; dexamethasone; CEM leukemia cells; arginine; polyamine; c-myc; p27(Kip1)
Categories
Ask authors/readers for more resources
Since arginine deiminase (ADI; EC 3.5.3.6) inhibits cell proliferation by arresting cells in the G(1) phase, we tested its synergistic effect on cell death induced by dexamethasone (DEX), which also induces apoptosis by G(1) cell cycle arrest. ADI inhibited cell proliferation and induced apoptosis in human leukemic CEM cells in a dose-dependent manner. Simultaneous treatment with ADI and DEX showed synergistic effects on DNA fragmentation and LDH release. In addition, ADI exerted its anti-proliferative activity against DEX-resistant CEM cells. ADI suppressed expression of c-myc, a potential key regulator of cell proliferation and apoptosis, and increased expression of p27(Kip1) cyclin-dependent kinase inhibitor. These results suggest that ADI efficiently increases the anti-cancer effect of DEX on human leukemic CEM cells through G(1) cell cycle arrest involving downregulation of c-myc and upregulation of p27(Kip1). (C) 2004 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available